Mexico Cell And Gene Therapy Manufacturing Market Size & Outlook
Mexico cell and gene therapy manufacturing market, 2018-2030 (US$M)
Related Markets
Mexico cell and gene therapy manufacturing market highlights
- The Mexico cell and gene therapy manufacturing market generated a revenue of USD 45.1 million in 2022 and is expected to reach USD 223.4 million by 2030.
- The Mexico market is expected to grow at a CAGR of 22.1% from 2023 to 2030.
- In terms of segment, cell therapy was the largest revenue generating therapy type in 2022.
- Gene Therapy is the most lucrative therapy type segment registering the fastest growth during the forecast period.
Cell and gene therapy manufacturing market data book summary
| Market revenue in 2022 | USD 45.1 million |
| Market revenue in 2030 | USD 223.4 million |
| Growth rate | 22.1% (CAGR from 2022 to 2030) |
| Largest segment | Cell therapy |
| Fastest growing segment | Gene Therapy |
| Historical data | 2018 - 2021 |
| Base year | 2022 |
| Forecast period | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Gene Therapy, Cell Therapy |
| Key market players worldwide | Lonza Group Ltd, Bluebird bio Inc, Catalent Inc, Roche, Samsung BioLogics, Boehringer Ingelheim, Hitachi Ltd, Takara Bio Inc, Miltenyi Biotec, Thermo Fisher Scientific Inc, Novartis AG ADR, Merck KGaA, Wuxi AppTec Co Ltd |
Other key industry trends
- In terms of revenue, Mexico accounted for 0.6% of the global cell and gene therapy manufacturing market in 2022.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Latin America, Brazil cell and gene therapy manufacturing market is projected to lead the regional market in terms of revenue in 2030.
- Brazil is the fastest growing regional market in Latin America and is projected to reach USD 342.1 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cell And Gene Therapy Manufacturing Market Scope
Cell And Gene Therapy Manufacturing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Mexico cell and gene therapy manufacturing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cell and gene therapy manufacturing market will help companies and investors design strategic landscapes.
Cell therapy was the largest segment with a revenue share of 66.96% in 2022. Horizon Databook has segmented the Mexico cell and gene therapy manufacturing market based on gene therapy, cell therapy covering the revenue growth of each sub-segment from 2018 to 2030.
In recent years, Mexico has gained increasing attention in medical tourism related to stem cell therapies. However, these stem cell therapies are unapproved. This may affect the manufacturing sector of cell & gene therapies.
Furthermore, increasing investments in R&D on stem cells is anticipated to drive demand in the country, in turn, leading to increase in revenues. For instance, in July 2019, Stem Cell Bank of Switzerland invested USD 50 million in the Mexican market to offer stem cell treatment services for diseases such as multiple sclerosis, diabetes, encephalopathies, & others.
Such growing investments are anticipated to accelerate cell and gene therapy manufacturing market. On the contrary, there are some challenges related to gene therapy, such as patentability and legal issues, in the country. Thus, an unclear legal framework may hamper adoption of gene therapy manufacturing, thereby restraining growth of gene delivery technologies in the country.
Reasons to subscribe to Mexico cell and gene therapy manufacturing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Mexico cell and gene therapy manufacturing market databook
-
Our clientele includes a mix of cell and gene therapy manufacturing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico cell and gene therapy manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into Mexico cell and gene therapy manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Mexico cell and gene therapy manufacturing market size, by therapy type, 2018-2030 (US$M)
Mexico Cell And Gene Therapy Manufacturing Market Outlook Share, 2022 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
